Jim Simons Agios Pharmaceuticals, Inc. Transaction History

Renaissance Technologies LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$21.32 - $34.81 $596,960 - $974,680	-28,000 Reduced 65.55%	14,714 $430,000
Q4 2023 Feb 13, 2024	BUY	$19.97 - $24.53 $852,998 - $1.05 Million	42,714 New	42,714 $951,000
Q3 2022 Nov 14, 2022	SELL	$19.51 - $34.14 $604,810 - $1.06 Million	-31,000 Reduced 50.0%	31,000 $877,000
Q2 2022 Aug 12, 2022	BUY	$17.06 - $31.42 $1.06 Million - $1.95 Million	62,000 New	62,000 $1.38 Million
Q4 2020 Feb 10, 2021	SELL	$33.21 - $46.54 $2.48 Million - $3.48 Million	-74,800 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$33.87 - $55.93 $2.53 Million - $4.18 Million	74,800 New	74,800 $2.62 Million
Q4 2019 Feb 13, 2020	SELL	$30.08 - $50.59 $3.64 Million - $6.12 Million	-121,000 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$32.4 - $49.58 $2.29 Million - $3.51 Million	70,700 Added 140.56%	121,000 $3.92 Million
Q2 2019 Aug 12, 2019	BUY	$46.17 - $68.1 $2.32 Million - $3.43 Million	50,300 New	50,300 $2.51 Million

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.26B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.